Dasatinib in imatinib-resistant or -intolerant chronic-phase, chronic myeloid leukemia patients: 7-year follow-up of study CA180-034-Reference-Cited by-同舟云学术

Dasatinib in imatinib-resistant or -intolerant chronic-phase, chronic myeloid leukemia patients: 7-year follow-up of study CA180-034

Published:2016-06-20 Issue:9 Volume:91 Page:869-874
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Shah Neil P.¹,Rousselot Philippe²,Schiffer Charles³,Rea Delphine⁴,Cortes Jorge E.⁵,Milone Jorge⁶,Mohamed Hesham⁷,Healey Diane⁷,Kantarjian Hagop⁵,Hochhaus Andreas⁸,Saglio Giuseppe⁹

Affiliation:

1. UCSF School of Medicine; San Francisco; California

2. Hôpital André Mignot and Université Versailles Saint-Quentin-en-Yvelines; Versailles France

3. Wayne State University School of Medicine; Detroit Michigan

4. Saint Louis Hospital; Paris France

5. University of Texas M.D. Anderson Cancer Center; Houston Texas

6. Hospital Italiano De La Plata; La Plata Argentina

7. Bristol-Myers Squibb; Princeton New Jersey

8. Universitätsklinikum Jena; Jena Germany

9. University of Turin; Turin Italy

Publisher

Wiley

Subject

Hematology

Reference19 articles.

1. Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: Follow-up of a phase 3 study;Shah;Blood,2014

2. Moving towards patient-centered decision-making in chronic myeloid leukemia: Assessment of quality of life and symptom burden;Baccarani;Haematologica,2014

3. International randomized study of interferon vs sti571 (IRIS) 8-year follow up: Sustained survival and low risk for progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib clinically [Abstract];Deininger;Blood,2009

4. Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: Analysis of patient data from six prospective clinical trials;Sasaki;Lancet Haematol,2015

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Choice of Frontline Tyrosine‐Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A “Campus CML” Study;European Journal of Haematology;2024-09-12

2. An association between Dasatinib, elevated left atrial pressure and pleural effusion;International Journal of Cardiology;2024-09

3. Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial;Leukemia;2024-08-20

4. Second-generation tyrosine kinase inhibitors in chronic myeloid leukemia today: efficacy and safety;Meditsinskiy sovet = Medical Council;2024-07-25

5. Exploring treatment decision-making in chronic myeloid leukemia in chronic phase;Frontiers in Oncology;2024-07-01